Background: The optimal number of examined lymph nodes (ELNs) and the prognostic value of different nodal staging systems remain unclear in the context of N3b gastric cancer. Aim: To evaluate the optimal number of ELNs and compare the predictive ability of the ELN number, LN ratio (LNR), and log odds of metastatic LNs (LODDS) for overall survival (OS) in patients with resected stage N3b gastric adenocarcinoma in an international database. Methods: A total of 868 patients diagnosed between 2004 and 2015 in the Surveillance, Epidemiology, and End Results (SEER) database (training cohort) and 144 patients diagnosed between 2011 and 2016 at the Liaoning Cancer Hospital (validation cohort) were identified. Cutoff values were established with X-tile. The 5-year OS rates were compared using Kaplan-Meier curves. Multivariate analysis was conducted with a Cox regression model. The Harrell's concordance index and Akaike's information criterion were used to compare the predictive accuracy of different nodal staging systems. Results: The ELN number, LNR, and LODDS were independent prognostic factors for both the training and validation cohorts in the multivariate analysis. Patient with ≤26 ELNs, LNR of more than 0.9, and LODDS of more than 1.0 were associated with decrease OS. The LNR and LODDS had similar discriminatory ability for OS and performed better than the ELN number in the Eastern and Western populations. Conclusion: The optimal number of ELN may be 27 or more because LNs retrieved ≤26 was an independent risk factor for the prognosis. The prognostic prediction efficacy of LNR and LODDS was similar and better than that of ELN. Thus, LNR and LODDS could both serve as valid tools to predict OS for stage N3b patients. K E Y W O R D S gastric adenocarcinoma, log odds of metastatic lymph nodes (LODDS), lymph node ratio (LNR), prognostic model, the optimal number of lymph node retrieved 1 INTRODUCTION Gastric cancer is the fifth most common cancer in the world and is the third leading cause of cancer mortality. 1 Gastric cancer ranks second among all cancers for incidence and mortality rates in China. 2 Lymph node (LN) metastasis is one of the most important prognostic indicators for survival outcomes. 3,4 From the fifth edition of the Union for International Cancer Control (UICC)/American Joint Committee on Cancer (AJCC) staging system to the eighth edition, the N stage has been based on the number of metastatic LNs (MLNs), and it is